Paul J. Mellett - 09 Jan 2023 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Treasurer and CFO
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
Issuer symbol
ENTA
Transactions as of
09 Jan 2023
Net transactions value
+$39,874
Form type
4
Filing time
10 Jan 2023, 18:11:57 UTC
Previous filing
19 Dec 2022
Next filing
13 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Options Exercise $39,874 +2,812 +3.3% $14.18 88,463 09 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (Right to Buy) Options Exercise $0 -2,812 -100% $0.000000* 0 09 Jan 2023 Common Stock 2,812 $14.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option are fully vested and exercisable.